Viral Orchitis and Male Infertility: A Comprehensive Review of Pathogenic Mechanisms and Outcomes

This narrative review covers how viruses like HIV and mumps damage testicular function—and admits current treatments fall short

Journal: Journal of Reproductive Immunology | Published: 2026-05-05 | Type: Review | PMID: 42107396 Authors: Prasanth C, Vickram AS, Bharath S, Bhavani Sowndharya B, Mathan Muthu CM (Saveetha School of Engineering, India); Chopra H (Chitkara University, India) Funding/COI: Funding not listed. Authors declare no competing financial interests.

Summary

This narrative review surveys how viral infections—primarily HIV and mumps—cause orchitis, which in turn damages spermatogenesis via direct cellular invasion and cytokine-mediated inflammation. The authors acknowledge that current antiviral and anti-inflammatory treatments have "suboptimal efficacy." They point to testicular organoid models and single-cell sequencing as emerging tools for understanding the disease better, but offer no new data of their own.

Claims

• HIV and mumps can directly infect testicular cells, triggering orchitis
• Viral infection of sperm cells causes decreased motility, reduced sperm count, and sperm cell death
• Inflammatory cytokine release is the primary mechanism disrupting spermatogenesis
• Epidemiological data links viral orchitis to male infertility and subfertility (no specific statistics cited in abstract)
• Current pharmacologic interventions—antiviral and anti-inflammatory agents—are described as having "suboptimal efficacy"
• Testicular organoid models and multi-omics technologies are identified as emerging research approaches

Study Quality

This is a narrative review with no declared systematic methodology—no PRISMA flow diagram, no search strategy, no inclusion/exclusion criteria described in the abstract. It synthesizes existing literature without quantitative pooling, which limits what conclusions can be drawn. The abstract cites no specific effect sizes, study counts, or patient numbers from the literature it reviews, making independent verification of the claims impossible without reading the full text.

All six authors share the same institution (Saveetha School of Engineering), which has a documented pattern of producing high-volume, low-methodology review papers. Saveetha appears repeatedly in lists of institutions with questionable publication practices. That doesn't automatically disqualify this review, but it warrants skepticism about rigor.

Red Flags

• No systematic review methodology declared—this is a "comprehensive review" by assertion only
• No quantitative data in the abstract: no pooled effect sizes, no sample sizes from cited studies, no p-values
• No funding source disclosed for a review of this scope
• All primary authors from the same single institution with known high-output review paper concerns
• Abstract language is vague ("largely inadequate," "suboptimal efficacy") without citing the specific evidence behind those judgments
• Claims about SARS-CoV-2/COVID-19 likely present in full text given the era, but not flagged in abstract—a common gap in these reviews

Strengths

• The topic is clinically relevant: viral orchitis is a real and underappreciated contributor to male infertility
• Identifying testicular organoids and single-cell sequencing as emerging tools reflects legitimate scientific directions
• The MeSH indexing is appropriately scoped (orchitis, spermatogenesis, male infertility)
• No competing financial interests, which removes one common source of bias

Verdict

This review appears to be a literature summary rather than a rigorous systematic review, produced by a high-volume institution with a documented track record of quantity over quality. The absence of any systematic methodology, the lack of quantitative claims in the abstract, and undisclosed funding are all yellow flags. The core subject matter—viral mechanisms of testicular damage—is legitimate and worth tracking, but this particular paper is not a reliable reference for specific statistics. Wait for a Cochrane-style systematic review or a well-powered epidemiological study before drawing firm conclusions about prevalence or treatment failure rates.